Literature DB >> 21757061

Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development.

Ellen D Mahan1, Kathleen M Morrow, John E Hayes.   

Abstract

BACKGROUND: Increasing prevalence of HIV infection among women worldwide has motivated the development of female-initiated prevention methods, including gel-based microbicides. User acceptability is vital for microbicide success; however, varying cultural vaginal practices indicate multiple formulations must be developed to appeal to different populations. Perceptual attributes of microbicides have been identified as primary drivers of acceptability; however, previous studies do not allow for direct comparison of these qualities between multiple formulations. STUDY
DESIGN: Six vaginal products were analyzed ex vivo using descriptive analysis. Perceptual attributes of samples were identified by trained participants (n=10) and rated quantitatively using scales based on a panel-developed lexicon. Data were analyzed using two-way ANOVAs for each attribute; product differences were assessed via Tukey's honestly significant difference test.
RESULTS: Significant differences were found between products for multiple attributes. Patterns were also seen for attributes across intended product usage (i.e., contraceptive, moisturizer or lubricant). For example, Options© Gynol II® (Caldwell Consumer Health, LLC) was significantly stickier and grainier than other products.
CONCLUSIONS: Descriptive analysis, a quantitative approach that is based on consensus lexicon usage among participants, successfully quantified perceptual differences among vaginal products. Since perceptual attributes of products can be directly compared quantitatively, this study represents a novel approach that could be used to inform rational design of microbicides.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757061      PMCID: PMC4699565          DOI: 10.1016/j.contraception.2010.11.012

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  21 in total

Review 1.  Microbicides: a new approach to preventing HIV and other sexually transmitted infections.

Authors:  Alan Stone
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

Review 2.  Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges.

Authors:  Sanjay Garg; Kaustubh R Tambwekar; Kavita Vermani; Raghupathi Kandarapu; Alka Garg; Donald P Waller; Lourens J D Zaneveld
Journal:  AIDS Patient Care STDS       Date:  2003-08       Impact factor: 5.078

3.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

4.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

5.  Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.

Authors:  M E Bentley; K M Morrow; A Fullem; M A Chesney; S D Horton; Z Rosenberg; K H Mayer
Journal:  Fam Plann Perspect       Date:  2000 Jul-Aug

6.  Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use.

Authors:  E Alexandra Zubowicz; Jennifer K Oakes; Mary B Short; Michelle M Perfect; Paul S Succop; Susan L Rosenthal
Journal:  J Womens Health (Larchmt)       Date:  2006-10       Impact factor: 2.681

7.  Acceptability of a microbicide among women and their partners in a 4-country phase I trial.

Authors:  Margaret E Bentley; Andrew M Fullem; Elizabeth E Tolley; Clifton W Kelly; Neelam Jogelkar; Namtip Srirak; Liness Mwafulirwa; Gertrude Khumalo-Sakutukwa; David D Celentano
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

8.  Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi.

Authors:  Cynthia Woodsong; Patty Alleman
Journal:  AIDS Educ Prev       Date:  2008-04

9.  Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.

Authors:  Rochelle K Rosen; Kathleen M Morrow; Alex Carballo-Diéguez; Joanne E Mantell; Susie Hoffman; Fang Gai; Lisa Maslankowski; Wafaa M El-Sadr; Kenneth H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2008-04       Impact factor: 2.681

10.  The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Authors:  Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2003-09       Impact factor: 2.681

View more
  10 in total

1.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

Review 2.  Designing and developing suppository formulations for anti-HIV drug delivery.

Authors:  Anthony S Ham; Robert W Buckheit
Journal:  Ther Deliv       Date:  2017-08

3.  Shape of vaginal suppositories affects willingness-to-try and preference.

Authors:  Bangde Li; Toral Zaveri; Gregory R Ziegler; John E Hayes
Journal:  Antiviral Res       Date:  2012-12-29       Impact factor: 5.970

Review 4.  On-demand microbicide products: design matters.

Authors:  Sravan Kumar Patel; Lisa Cencia Rohan
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

Review 5.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

6.  Relationships between perceptual attributes and rheology in over-the-counter vaginal products: a potential tool for microbicide development.

Authors:  Ellen D Mahan; Toral Zaveri; Gregory R Ziegler; John E Hayes
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

7.  A Comparison of Two Sensory Panels Trained with Different Feedback Calibration Range Specifications via Sensory Description of Five Beers.

Authors:  Line Elgaard; Line A Mielby; Helene Hopfer; Derek V Byrne
Journal:  Foods       Date:  2019-11-01

8.  User preferences in a carrageenan-based vaginal drug delivery system.

Authors:  Bangde Li; Toral Zaveri; Gregory R Ziegler; John E Hayes
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint Analysis.

Authors:  Rachel J Primrose; Toral Zaveri; Alyssa J Bakke; Gregory R Ziegler; Howard R Moskowitz; John E Hayes
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

10.  Antimicrobial Activity of a Vaginal Gel Formulation: Considerations Related to Vaginal Infection and Dysbiosis.

Authors:  Francesco De Seta; Bryan Larsen
Journal:  Pathogens       Date:  2021-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.